Extracellular CypA plays vital roles in acute and chronic inflammation-related human diseases such as viral infection, rheumatoid arthritis (26), periodontitis (27) and cardiovascular diseases, and CypA-1-specific inhibitors can be used as effective targets for treating inflammation-related diseases. Here, PPIA is linked to periodontitis.